Editorial: Focus on cutaneous host-defense failure in transplant recipients.
D001379:Azathioprine / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects; D006561:Herpes Simplex / Q000209:etiology; D006562:Herpes Zoster / Q000209:etiology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D016030:Kidney Transplantation; D008722:Methods; D010587:Phagocytosis / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D011241:Prednisone / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000139:chemically induced; D013601:T-Lymphocytes / Q000187:drug effects; D013997:Time Factors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014946:Wound Infection / Q000209:etiology
D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone